Triall brings Web 3.0 to medical research. We create a digital ecosystem of blockchain-integrated software solutions to secure and streamline the development of new vaccines and therapeutics during clinical trials.
Our blockchain infrastructure makes clinical trial data tamper-resistant. It also enables secure and efficient integrations between the many isolated systems and parties involved in clinical trial processes.
Our software is created by clinical trial professionals to ensure optimal user experience, solving actual industry pain points.
Combined, our team has managed 100+ clinical trials across 30+ countries, and successfully grown companies both in the Life Sciences and Software/Blockchain-as-a-Service industries.
Our team has published 250+ peer-reviewed papers on innovation in medical research, featured in top-tier scientific journals such as Nature and Science.
Years of industry operations have gained us a strong value network of partners and potential customers. It allows us to effectively bring our solutions to market.
Our target market is characterized by rapid digitalization, decentralization, and double-digit growth (CAGR of 13.8%). High upside is projected for those that can underpin this emerging digital ecosystem. Our solutions are specifically designed to do so.
Our first product Verial eTMF is in production and currently being onboarded by 6 real-world clinical trials across 3 countries, involving an approximate total of 2500 participants. More projects are lined up.
Leading stakeholders in our customer domain have expressed interest in our first products, which directly respond to actual customer pain points.
As a first demonstration of our blockchain-integrated ecosystem, we are releasing a series of targeted clinical trial software applications. We have been working closely with the medical research industry to ensure that each of these ‘eClinical solutions’ solves actual industry pain points.
The underlying product concepts have been validated with a Seal of Excellence by industry experts of the European Commission’s Horizon2020 program for Top research and innovation.
Our modular but complementary eClinical solutions are all designed to greatly improve data integrity, auditability, and task efficiency in modern-day clinical trial processes. These functionalities answer to growing calls for data security and traceability by industry regulators across the globe.
Empathetic and tireless leader with extensive clinical development expertise. Innovator and team builder. Founder of multiple successful service companies in the Life Sciences.
Experienced blockchain and SaaS developer. Serial tech entrepreneur with 15+ years’ experience in various CTO roles. Director of the Factom Blockchain.
Academic entrepreneur, project manager and consultant. Co-founder of two successful Life Sciences management consultancies. Holds a cum laude PhD in science commercialization.
Corporate lawyer and deal-maker with extensive experience as legal counsel in the pharma & health care industries. Headed the legal department of Erasmus University Medical Center.
Researcher, consultant, and copywriter with a background in Biomedical Sciences and Entrepreneurship. Passion for making complex technologies understandable for a broader audience.
Clinical researcher, project manager and medical writer, operating at the interface between industry and academia. Early crypto enthusiast, dedicated to realizing end-user functionalities.
PhD candidate and consultant in medical innovation management with degrees in Health Technology Assessment and Management. Passionate designer with 12 years’ experience in UI / UX projects.
I have over 12 years of experience in designing and managing clinical research projects, working for major companies like AstraZeneca and Novartis. I see this as a much-needed project with great potential.”
“The team is at the pinnacle of professionalism, from marketing and management down to the engagement with the community and investors. I feel exceptionally privileged to be involved, and am excited to watch Triall blossom into a world-renowned brand.”
“With a solid line of products behind it all, promising to bring smarter, safer, and more-efficient clinical trials to the world, Triall should not be missing from any serious investor portfolio. So much potential.”
When I first got in touch with the Triall team, I was so impressed with their professionalism. It was a no-brainer for me to involve my team of investors in backing this project.”
Everything Triall has presented so far indicates that it will be one of the most solid tokens on the market.”
I’m a marketing consultant for several alt coins. This token, in my opinion is solving a real pain point that exists today. To use blockchain to authenticate clinical trials is genius.”
As soon as I saw what Triall is doing, it captured my attention. Not only the tech and applications they are building are top notch, but the team is dedicated and professional. With industry leaders in the medical field on their side, there is no doubt in my head Triall will make a change in the medical trial industry and that the project will be successful.”
Last updated: Sep 22, 2021 * Total of the Private and Retail Pre-sale pools combined. Excludes the Late Bird Pre-sale pool, and tokens offered through the ProStarter and Trustpad IDOs. Full overview of all token pools can be found here.
The $TRL smart contracts have been audited by blockchain security group Zokyo.io, receiving the maximum security score of 100/100. You can see the full audit report here.
Any unsold tokens from the Triall pre-sale will be burned.
